PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Van Coillie, S.* ; Van San, E.* ; Goetschalckx, I.* ; Wiernicki, B.* ; Mukhopadhyay, B.* ; Tonnus, W.* ; Choi, S.M.* ; Roelandt, R.* ; Dumitrascu, C.* ; Lamberts, L.E.* ; Dams, G.* ; Weyts, W.* ; Huysentruyt, J.* ; Hassannia, B.* ; Ingold, I. ; Lele, S.* ; Meyer, E.* ; Berg, M.* ; Seurinck, R.* ; Saeys, Y.* ; Vermeulen, A.* ; van Nuijs, A.L.N.* ; Conrad, M. ; Linkermann, A.* ; Rajapurkar, M.* ; Vandenabeele, P.* ; Hoste, E.* ; Augustyns, K.* ; Vanden Berghe, T.*

Targeting ferroptosis protects against experimental (multi)organ dysfunction and death.

Nat. Commun. 13:1046 (2022)
Verlagsversion Forschungsdaten DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
The most common cause of death in the intensive care unit (ICU) is the development of multiorgan dysfunction syndrome (MODS). Besides life-supporting treatments, no cure exists, and its mechanisms are still poorly understood. Catalytic iron is associated with ICU mortality and is known to cause free radical-mediated cellular toxicity. It is thought to induce excessive lipid peroxidation, the main characteristic of an iron-dependent type of cell death conceptualized as ferroptosis. Here we show that the severity of multiorgan dysfunction and the probability of death are indeed associated with plasma catalytic iron and lipid peroxidation. Transgenic approaches underscore the role of ferroptosis in iron-induced multiorgan dysfunction. Blocking lipid peroxidation with our highly soluble ferrostatin-analogue protects mice from injury and death in experimental non-septic multiorgan dysfunction, but not in sepsis-induced multiorgan dysfunction. The limitations of the experimental mice models to mimic the complexity of clinical MODS warrant further preclinical testing. In conclusion, our data suggest ferroptosis targeting as possible treatment option for a stratifiable subset of MODS patients.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
17.694
3.341
8
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Sprache englisch
Veröffentlichungsjahr 2022
HGF-Berichtsjahr 2022
ISSN (print) / ISBN 2041-1723
e-ISSN 2041-1723
Zeitschrift Nature Communications
Quellenangaben Band: 13, Heft: 1, Seiten: , Artikelnummer: 1046 Supplement: ,
Verlag Nature Publishing Group
Verlagsort London
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Metabolism and Cell Death (MCD)
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-506900-001
Förderungen German Research Foundation (DFG)
German Federal Ministry of Education and Research VIP+program
Ministry of Science and Higher Education of The Russian Federation
European Research Council (ERC)
FWO
Strategic Basic Research Foundation Flanders, IRONIX
Methusalem
Flemish Institute of Biotechnology VIB
FWO-SBO
iBOF20/IBF/039 ATLANTIS
VLIRUOS
Charcot Foundation
Foundation against cancer
UGent Special research fund
Industrial Research Fund from Ghent University
Industrial research Fund from University of Antwerp
Consortium of excellence at University of Antwerp INFLA-MED
EOS INFLADIS
Excellence of Science MODEL-IDI
DOI 10.1038/s41467-022-28718-6
WOS ID WOS:000769633800019
Scopus ID 85125340646
PubMed ID 35210435
Erfassungsdatum 2022-05-02
[➜Korrektur melden]